Stereotactic Body Radiation Therapy and the Influence of Chemotherapy on Overall Survival for Large (≥5 Centimeter) Non-Small Cell Lung Cancer.
about
Advances in radiotherapy techniques and delivery for non-small cell lung cancer: benefits of intensity-modulated radiation therapy, proton therapy, and stereotactic body radiation therapy.Target migration from re-inflation of adjacent atelectasis during lung stereotactic body radiotherapy.Multi-institutional experience of stereotactic body radiotherapy for large (≥5 centimeters) non-small cell lung tumors.Chemotherapy Versus Chemoradiation for Node-Positive Bladder Cancer: Practice Patterns and Outcomes from the National Cancer Data Base.The role of adjuvant chemotherapy in locally advanced bladder cancer.Management of pathologic node-positive disease following initial surgery for clinical T1-2 N0 esophageal cancer: patterns of care and outcomes from the national cancer data base.Addition of chemotherapy to hypofractionated radiotherapy for glioblastoma: practice patterns, outcomes, and predictors of survival.Human papillomavirus and nasopharyngeal cancer.Radiation dose in neoadjuvant chemoradiation therapy for esophageal cancer: patterns of care and outcomes from the National Cancer Data Base.Utilization of neoadjuvant intensity-modulated radiation therapy and proton beam therapy for esophageal cancer in the United States.Practice patterns and outcomes of chemoradiotherapy versus radiotherapy alone for older patients with nasopharyngeal cancer.Utilization of intensity modulated radiation therapy for anal cancer in the United States.Trends and disparities in the utilization of hypofractionated neoadjuvant radiation therapy for rectal cancer in the United StatesStereotactic body radiation therapy (SBRT) for early stage non-small cell lung cancer (NSCLC): contemporary insights and advances
P2860
Q33645619-A30FB8FC-5C5B-4F2A-80B5-B314FDF4FF49Q33779902-B9FD7751-37AE-4A92-8D5D-90A4142A0E81Q40542033-AF484F5A-C3FF-40A8-B8D3-9374FD2FCABDQ47109420-4F8A71A6-8999-4B5B-98F8-BE99D6F19FAFQ47332651-583FD081-5D0C-4600-87D9-7C9ED8AE3978Q47393450-C80021D8-45D1-4D29-A7CC-DA82021069BDQ47678703-C413354F-CD31-4F40-9365-CA46DE98E293Q48261411-BB9DEF1F-855C-4994-A6C1-88E997EFAD00Q53276116-41511D23-B5B9-41EA-8288-69CADB14C158Q55025183-D55ADBCA-7132-48AF-BBE8-5CA253656B61Q55257494-5E44A12A-1123-4A80-949D-7A352931A46CQ55714403-1A95488C-5536-4574-842E-3122C81E3FD9Q57172701-4ECB2914-8784-4E65-B83D-5BA2225FDD37Q57172947-B80A8FC0-4DEB-448D-A1DE-A86EC569B6AA
P2860
Stereotactic Body Radiation Therapy and the Influence of Chemotherapy on Overall Survival for Large (≥5 Centimeter) Non-Small Cell Lung Cancer.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Stereotactic Body Radiation Th ...... r) Non-Small Cell Lung Cancer.
@en
Stereotactic Body Radiation Th ...... on Overall Survival for Large
@nl
type
label
Stereotactic Body Radiation Th ...... r) Non-Small Cell Lung Cancer.
@en
Stereotactic Body Radiation Th ...... on Overall Survival for Large
@nl
prefLabel
Stereotactic Body Radiation Th ...... r) Non-Small Cell Lung Cancer.
@en
Stereotactic Body Radiation Th ...... on Overall Survival for Large
@nl
P1476
Stereotactic Body Radiation Th ...... er) Non-Small Cell Lung Cancer
@en
P2093
Surbhi Grover
Vivek Verma
P304
P356
10.1016/J.IJROBP.2016.09.036
P407
P577
2016-09-29T00:00:00Z